After the "722" incident, the FDA on-site inspection of the first occurrence of "OAI" in Chinese clinical trial institutions (serious problems requiring official administrative measures)!

Congratulations! China's "Nobel Prize" was awarded to Professor Deng Hongkui, a stem cell scientist at Peking University!

iPSC treats hundreds of billions of CNS diseases, and many domestic companies have achieved the "first" results

MSCs and iPSC: Exploring the Future of Stem Cell Therapy

Stem cell therapy has conducted more than 6000 clinical trials for 10 major systemic diseases and more than 200 indications